Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TranspoCART19 |
Trade Name | |
Synonyms | Transpo-CART19|Transpo CART19 |
Drug Descriptions |
Limited information is currently available on a TranspoCART19, a putative chimeric antigen receptor (CAR) T-cell therapy targeting CD19 and containing TNFRSF9 (4-1BB) co-stimulatory region, CD3z, and huEGFRt (Jun 2024). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TranspoCART19 | TranspoCART19 | 0 | 1 |